Publications by authors named "Harsh B Pathak"

Claim this Profile
D
Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles.
Jared Sipes, Didi Zha, Sagar Rayamajhi, Leonidas E Bantis, Rashna Madan, Harsh B Pathak

Cancer Res Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into Keratinocyte and Immunologic Landscape in Cutaneous Graft-Versus-Host Disease through Single-Cell Transcriptomics.
Amy J Petty, Adela Rambi Cardones, Yingai Jane Jin, Vaibhav Jain, Emily Hocke, Harsh B Pathak

JID Innov· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of Aurora Kinase A and poly (ADP-ribose) polymerase as a therapeutic option for patients with ovarian cancer: preclinical evaluations.
Soumya M Turaga, Stacey L Hembruff, Masha G Savelieff, Arnab Ghosh, Rajni V Puri, Harsh B Pathak

J Cancer Res Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial transcriptomic profiling of the human fallopian tube epithelium reveals region-specific gene expression patterns.
Jared Sipes, Sagar Rayamajhi, Leonidas E Bantis, Rashna Madan, Amrita Mitra, Harsh B Pathak

Commun Biol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model.
Vijayalaxmi G Gupta, Katherine F Roby, Harsh B Pathak, Andrew K Godwin, Sumedha Gunewardena

BMC Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational Implications of The Gut Microbiome in Women with A Benign or Malignant Pelvic Mass.
Priya Sabu, Harsh B Pathak, Emily Nissen, Prabhakar Chalise, Devin C Koestler

Ann Obstet Gynecol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking Small Extracellular Vesicles Using a Minimally Invasive PicoGreen Labeling Strategy.
Sagar Rayamajhi, Benjamin K Gibbs, Jared Sipes, Harsh B Pathak, Stefan H Bossmann

ACS Appl Bio Mater· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility Study of Adverse Childhood Experiences, Treatment-Related Sequelae, and Inflammatory Markers in Breast Cancer Survivors.
Lori Ranallo, Harsh B Pathak, Jianghua He, Jaromme Geebum Kim, Karla Van Goethem

Oncol Nurs Forum· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer.
Camille V Trinidad, Harsh B Pathak, Shibo Cheng, Shin-Cheng Tzeng, Rashna Madan

Sci Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inducing Mitotic Catastrophe as a Therapeutic Approach to Improve Outcomes in Ewing Sarcoma.
Soumya M Turaga, Vikalp Vishwakarma, Stacey L Hembruff, Benjamin K Gibbs, Priya Sabu, Harsh B Pathak

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.
Shane R Stecklein, Bruce F Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M Staley, Harsh B Pathak

NPJ Breast Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Immunotherapy with Check-Point Inhibitors: Prospective Assessment of Cognitive Function.
Jamie S Myers, Adam C Parks, Jonathan D Mahnken, Kate J Young, Harsh B Pathak

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic Profiling of Fallopian Tube-Derived Extracellular Vesicles Using a Microfluidic Tissue-on-Chip System.
Didi Zha, Sagar Rayamajhi, Jared Sipes, Angela Russo, Harsh B Pathak

Bioengineering (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
Eve Rodler, Priyanka Sharma, William E Barlow, Julie R Gralow, Shannon L Puhalla, Harsh B Pathak

Lancet Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Exercise and Game-Based Cognitive Training Intervention: Correlative Pilot Study of Neurotrophic and Inflammatory Biomarkers for Women With Breast Cancer.
Jamie Myers, Harsh B Pathak, Jianghua He, Arnab Ghosh, Rajni V Puri

Cancer Nurs· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients.
Qamar J Khan, Cory R Bivona, Ben Liu, Maggie Nelson, Grace A Martin, Harsh B Pathak

Bone Marrow Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of biomarkers from a pilot weight management study for men undergoing radical prostatectomy.
Mohamad Dave Dimachkie, Misty D Bechtel, Hilary L Robertson, Carrie Michel, Eugene K Lee, Harsh B Pathak

Urol Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer.
Priyanka Sharma, Vandana G Abramson, Anne O'Dea, Lauren Nye, Ingrid Mayer, Harsh B Pathak

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer.
Vijayalaxmi G Gupta, Jeff Hirst, Shariska Petersen, Katherine F Roby, Meghan Kusch, Harsh B Pathak

Gynecol Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation.
Geun-Young Park, Harsh B Pathak, Andrew K Godwin, Youngjoo Kwon

Cell Oncol (Dordr)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1.
Meizhang Li, Rupal Soder, Sunil Abhyankar, Haitham Abdelhakim, Mitchell W Braun, Harsh B Pathak

J Extracell Vesicles· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer.
Mitchell W Braun, Haitham Abdelhakim, Meizhang Li, Stephen Hyter, Ziyan Pessetto, Harsh B Pathak

J Immunother Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial.
Priyanka Sharma, William E Barlow, Andrew K Godwin, Eileen E Parkes, Laura A Knight, Harsh B Pathak

J Clin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation and breast density among female Chinese immigrants: exploring variations across neighborhoods.
Carolyn Y Fang, Brian L Egleston, Celia Byrne, Gregory S Bohr, Harsh B Pathak

Cancer Causes Control· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties.
Jeff Hirst, Harsh B Pathak, Stephen Hyter, Ziyan Y Pessetto, Thuc Ly

Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis